Susceptibility of Clostridium difficile isolates from a Phase 2 clinical trial of cadazolid and vancomycin in C. difficile infection. (Record no. 25322069)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01843 a2200553 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517054749.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201610s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1460-2091 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1093/jac/dkv300 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Gerding, D N |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20161005 |
| 245 00 - TITLE STATEMENT | |
| Title | Susceptibility of Clostridium difficile isolates from a Phase 2 clinical trial of cadazolid and vancomycin in C. difficile infection. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | The Journal of antimicrobial chemotherapy |
| Date of publication, distribution, etc. | Jan 2016 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 213-9 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adolescent |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged, 80 and over |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Anti-Bacterial Agents |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Clostridioides difficile |
| General subdivision | classification |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Clostridium Infections |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Double-Blind Method |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Microbial Sensitivity Tests |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Oxazolidinones |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Ribotyping |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Vancomycin |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Young Adult |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hecht, D W |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Louie, T |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Nord, C E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Talbot, G H |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Cornely, O A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Buitrago, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Best, E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sambol, S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Osmolski, J R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kracker, H |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Locher, H H |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Charef, P |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wilcox, M |
| 773 0# - HOST ITEM ENTRY | |
| Title | The Journal of antimicrobial chemotherapy |
| Related parts | vol. 71 |
| -- | no. 1 |
| -- | p. 213-9 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1093/jac/dkv300">https://doi.org/10.1093/jac/dkv300</a> |
| Public note | Available from publisher's website |
No items available.